Features of the Course of Chronic Heart Failure Resistant to Antiplant Therapy
Keywords:
Heart failure, antiplatelet therapy, thrombosis, acetylsalicylic acid, arterial hypertension, atherothrombosisAbstract
Heart failure is a major public health problem and, despite optimal medical therapy, morbidity and mortality remain high. Over the past 20 years, in the problem of chronic heart failure (CHF) there have been many changes that can be characterized as evolutionary. This article about main changes regarding etiology, prevalence of resistance to antiplatelet therapy, as well as mortality in patients with CHF.
References
Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. DOI:10.1161/CIRCHEARTFAILURE.119.006472:e006472
Эпидемиология и прогноз хронической сердечной недостаточности’’ Беленков Ю.Н. , Агеев Ф.Т.
The epidemiology of heart failure: Framingham Study. Ho KK, Pinsky JL, Kannel WB et.al. J Am Coll Cardiol 1993;22(suppl A):6A-13A.
Осипова О.А., Нагибина А.И., Власенко О.А и др. Анализ иммунновоспалительных механизмов в развитии и прогрессировании хронической сердечной недостаточности. Системный анализ и управление в биомедицинских системах. 2014;13 (1):21-25. ISSN: 1682- 6523
Manzano L, Babalis D, Roughton M et al. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail. 2011;13(5):528-536. doi:10.1093/eurjhf/hfr030
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 / European Heart Journal. – 2012 Vol. – 33 – P. 1787–1847.
PROGRESS Collaborative Group. Randomized trial of a perindopril – based blood–pressure–lowering regimen among 6105 individuals with previous stroke or transient ischemic attack / Lancet. – 2001 – 358 – Р. 1033–1041.
Sharifovna, N. G. (2023). FEATURES OF THE QUALITY OF LIFE OF PATIENTS WITH RESPIRATORY DISEASES AND THEIR DYNAMICS DURING STATIONARY TREATMENT. International Journal of Integrative and Modern Medicine, 1(1), 66-73.
